AQR Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $193M | Sell |
888,913
-261,833
| -23% | -$58.1M | 0.09% | 311 |
|
|
2025
Q4 | $263M | Buy |
1,150,746
+223,904
| +24% | +$51M | 0.14% | 188 |
|
|
2025
Q3 | $210M | Buy |
926,842
+328,850
| +55% | +$67M | 0.13% | 201 |
|
|
2025
Q2 | $110M | Sell |
597,992
-176,114
| -23% | -$32.7M | 0.09% | 318 |
|
|
2025
Q1 | $159M | Sell |
774,106
-674,261
| -47% | -$131M | 0.16% | 155 |
|
|
2024
Q4 | $256M | Sell |
1,448,367
-263,367
| -15% | -$48.4M | 0.33% | 49 |
|
|
2024
Q3 | $333M | Buy |
1,711,734
+307,306
| +22% | +$57.4M | 0.46% | 28 |
|
|
2024
Q2 | $238M | Sell |
1,404,428
-134,055
| -9% | -$22.2M | 0.36% | 46 |
|
|
2024
Q1 | $278M | Sell |
1,538,483
-306,614
| -17% | -$52.8M | 0.47% | 30 |
|
|
2023
Q4 | $286M | Buy |
1,845,097
+348,011
| +23% | +$50.7M | 0.54% | 24 |
|
|
2023
Q3 | $223M | Buy |
1,497,086
+331,662
| +28% | +$48.7M | 0.46% | 36 |
|
|
2023
Q2 | $155M | Sell |
1,165,424
-28,800
| -2% | -$4.22M | 0.33% | 65 |
|
|
2023
Q1 | $189M | Sell |
1,194,224
-227,583
| -16% | -$34.8M | 0.41% | 44 |
|
|
2022
Q4 | $229M | Sell |
1,421,807
-36,141
| -2% | -$5.54M | 0.52% | 29 |
|
|
2022
Q3 | $196M | Sell |
1,457,948
-208,400
| -13% | -$29.9M | 0.48% | 27 |
|
|
2022
Q2 | $253M | Sell |
1,666,348
-131,592
| -7% | -$20.1M | 0.57% | 22 |
|
|
2022
Q1 | $291M | Sell |
1,797,940
-232,348
| -11% | -$33.8M | 0.55% | 24 |
|
|
2021
Q4 | $275M | Buy |
2,030,288
+57,832
| +3% | +$6.83M | 0.5% | 33 |
|
|
2021
Q3 | $213M | Buy |
1,972,456
+103,628
| +6% | +$11.8M | 0.39% | 45 |
|
|
2021
Q2 | $209M | Sell |
1,868,828
-387,539
| -17% | -$43.6M | 0.36% | 54 |
|
|
2021
Q1 | $243M | Sell |
2,256,367
-205,311
| -8% | -$22M | 0.4% | 52 |
|
|
2020
Q4 | $260M | Sell |
2,461,678
-1,210,419
| -33% | -$116M | 0.46% | 39 |
|
|
2020
Q3 | $319M | Sell |
3,672,097
-1,653,574
| -31% | -$156M | 0.54% | 29 |
|
|
2020
Q2 | $512M | Buy |
5,325,671
+2,296,582
| +76% | +$202M | 0.83% | 16 |
|
|
2020
Q1 | $231M | Buy |
3,029,089
+1,257,587
| +71% | +$107M | 0.39% | 53 |
|
|
2019
Q4 | $157M | Buy |
1,771,502
+623,364
| +54% | +$51.8M | 0.18% | 148 |
|
|
2019
Q3 | $86.5M | Sell |
1,148,138
-1,789,134
| -61% | -$123M | 0.1% | 240 |
|
|
2019
Q2 | $212M | Sell |
2,937,272
-2,039,418
| -41% | -$160M | 0.24% | 120 |
|
|
2019
Q1 | $400M | Buy |
4,976,690
+950,737
| +24% | +$77.8M | 0.42% | 48 |
|
|
2018
Q4 | $371M | Sell |
4,025,953
-967,494
| -19% | -$85.1M | 0.43% | 57 |
|
|
2018
Q3 | $472M | Buy |
4,993,447
+931,390
| +23% | +$88.3M | 0.45% | 54 |
|
|
2018
Q2 | $380M | Sell |
4,062,057
-938,798
| -19% | -$91.7M | 0.38% | 60 |
|
|
2018
Q1 | $473M | Buy |
5,000,855
+507,695
| +11% | +$55.8M | 0.51% | 40 |
|
|
2017
Q4 | $435M | Buy |
4,493,160
+752,859
| +20% | +$71M | 0.46% | 46 |
|
|
2017
Q3 | $332M | Buy |
3,740,301
+2,845,510
| +318% | +$217M | 0.4% | 57 |
|
|
2017
Q2 | $64.9M | Sell |
894,791
-46,033
| -5% | -$3.09M | 0.09% | 303 |
|
|
2017
Q1 | $61.3M | Buy |
940,824
+347,710
| +59% | +$21.9M | 0.08% | 333 |
|
|
2016
Q4 | $37.1M | Sell |
593,114
-63,576
| -10% | -$3.88M | 0.05% | 456 |
|
|
2016
Q3 | $41.4M | Buy |
656,690
+132,726
| +25% | +$8.59M | 0.06% | 411 |
|
|
2016
Q2 | $32.4M | Sell |
523,964
-544,432
| -51% | -$33.2M | 0.06% | 441 |
|
|
2016
Q1 | $61M | Sell |
1,068,396
-283,076
| -21% | -$15.8M | 0.11% | 255 |
|
|
2015
Q4 | $80.1M | Buy |
1,351,472
+125,319
| +10% | +$7.22M | 0.14% | 200 |
|
|
2015
Q3 | $66.7M | Sell |
1,226,153
-2,241,420
| -65% | -$146M | 0.13% | 212 |
|
|
2015
Q2 | $233M | Sell |
3,467,573
-3,259,104
| -48% | -$213M | 0.46% | 40 |
|
|
2015
Q1 | $394M | Buy |
6,726,677
+2,718,701
| +68% | +$164M | 0.9% | 8 |
|
|
2014
Q4 | $262M | Buy |
4,007,976
+1,501,101
| +60% | +$94.6M | 0.55% | 20 |
|
|
2014
Q3 | $145M | Sell |
2,506,875
-773,075
| -24% | -$42.9M | 0.4% | 47 |
|
|
2014
Q2 | $185M | Buy |
3,279,950
+314,100
| +11% | +$16.5M | 0.5% | 30 |
|
|
2014
Q1 | $152M | Buy |
2,965,850
+1,953,268
| +193% | +$98.7M | 0.46% | 38 |
|
|
2013
Q4 | $53.5M | Buy |
1,012,582
+703,435
| +228% | +$34.6M | 0.16% | 165 |
|
|
2013
Q3 | $13.8M | Buy |
+309,147
| New | +$13.7M | 0.05% | 455 |
|
Other funds holding ABBV
VCM
VPM
AQR Capital Management's ABBV Position: Q1 2026 in Review
AQR Capital Management reduced its AbbVie (ABBV) stake by 23% in Q1 2026, selling an estimated $58.1M and leaving 888,913 shares worth $193M. The position accounts for 0.09% of the portfolio, ranked #311.
AQR Capital Management first reported a position in ABBV in Q3 2013 and has held it in 51 quarters since. The position peaked at $512M in Q2 2020. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- AQR Capital Management held 888,913 shares of AbbVie worth $193M as of Q1 2026.
- AQR Capital Management sold 261,833 AbbVie shares in Q1 2026, an estimated $58.1M.
- AbbVie made up 0.09% of AQR Capital Management's portfolio in Q1 2026, its #311 holding.
- AQR Capital Management first reported a position in AbbVie in Q3 2013 and has held it in 51 quarters since.
- AQR Capital Management's AbbVie position peaked at $512M in Q2 2020.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.